Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes

The immunological mechanism(s) of action whereby teplizumab preserves C-peptide levels in the progression of patients with recent onset type 1 diabetes (T1D) is still not well understood. In the present study, we evaluated the kinetics of T cell modulation in peripheral blood following two 14-day co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Immunol
Main Authors: Long, S. Alice, Thorpe, Jerill, Herold, Kevan C., Ehlers, Mario, Sanda, Srinath, Lim, Noha, Linsley, Peter S., Nepom, Gerald T., Harris, Kristina M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5614459/
https://ncbi.nlm.nih.gov/pubmed/28844471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2017.07.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados